Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q3 EPS of ($0.77), $0.18 better than the analyst estimate of ($0.95).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.